Corticobasal syndrome with tau pathology

Movement Disorders

Volumn 16, Issue 4, 2001, Pages 656-667

  Cordato, N J ^a,b   Halliday, G M ^a   McCann, H ^a   Davies, L ^c   Williamson, P ^d   Fulham, M ^c   Morris, J G L ^b  

^a NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^d ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Brain atrophy; Corticobasal degeneration; Neuropathology; Precentral gyrus; Progressive supranuclear palsy; Tau

Indexed keywords

BENSERAZIDE PLUS LEVODOPA; LEVODOPA; TAU PROTEIN;

ADULT; AGED; APRAXIA; AUTOPSY; BASAL GANGLION; BODY POSTURE; BRAIN ATROPHY; BRAIN CORTEX; BRAIN SIZE; BRAIN TISSUE; CELL LOSS; CLINICAL FEATURE; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; FEMALE; GAZE PARALYSIS; GLIOSIS; GLOBUS PALLIDUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NERVE CELL; PARKINSONISM; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; REVIEW; TAUOPATHY; VOLUMETRY;

AGED; APRAXIA, IDEOMOTOR; ATROPHY; BASAL GANGLIA; BRAIN; CEREBRAL CORTEX; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURONS; PARKINSONIAN DISORDERS; SUPRANUCLEAR PALSY, PROGRESSIVE; TAU PROTEINS;

EID: 0035412879     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.1124     Document Type: Review

References (58)

1. Litvan I, Agid Y, Goetz C, Jankovic J, Wenning GK, Brandel JP, et al. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology 1997;48:119-125.
2. Litvan I, Grimes DA, Lang AE, Jankovic J, McKee A, Verny M, et al. Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration. J Neurol 1999;246 Suppl 2:II1-5.
3. Wenning GK, Litvan I, Jankovic J, Granata R, Mangone CA, McKee A, et al. Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J Neurol Neurosurg Psychiatry 1998;64:184-189.
4. Collins SJ, Ahlskog JE, Paris JE, Maraganore DM. Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria. J Neurol Neurosurg Psychiatry 1995;58:167-173.
5. Bergeron C, Pollanen MS, Weyer L, Lang AE. Cortical degeneration in progressive supranuclear palsy. A comparison with cortical-basal ganglionic degeneration. J Neuropathol Exp Neurol 1997;56: 726-734.
6. Barclay CL, Bergeron C, Lang AE. Arm levitation in progressive supranuclear palsy. Neurology 1999;52:879-882.
7. Kaida K, Takeda K, Nagata N, Kamakura K. Alzheimer's disease with asymmetric parietal lobe atrophy: a case report. J Neurol Sci 1998;160:96-99.
8. Grimes DA, Bergeron CB, Lang AE. Motor neuron disease-inclusion dementia presenting as cortical-basal ganglionic degeneration. Mov Disord 1999;14:674-680.
9. Horoupian DS, Wasserstein PH. Alzheimer's disease pathology in motor cortex in dementia with Lewy bodies clinically mimicking corticobasal degeneration. Acta Neuropathol (Berl) 1999;98:317-322.
10. Boeve BF, Maraganore DM, Parisi JE, Ahlskog JE, Graff-Radford N, Caselli RJ, et al. Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology 1999;53:795-800.
11. Bhatia KP, Lee MS, Rinne JO, Revesz T, Scaravilli F, Davies L, et al. Corticobasal degeneration look-alikes. Adv Neurol 2000;82: 169-182.
12. Feany MB, Dickson DW. Neurodegenerative disorders with extensive tau pathology: a comparative study and review. Ann Neurol 1996;40:139-148.
13. Komori T, Arai N, Oda M, Nakayama H, Mori H, Yagishita S, et al. Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol (Berl) 1998;96:401-408.
14. Dickson DW. Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration. J Neurol 1999;246 Suppl 2:II6-15.
15. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47: 1113-1124.
16. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathological assessment of Alzheimer's disease. Neurology 1991;41:479-486.
17. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239-259.
18. Delacourte A, Buée L. Tau pathology: a marker of neurodegenerative disorders. Curr Opin Neurol 2000;13:371-376.
19. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski Syndrome): report of the NINDS-SPSP International Workshop. Neurology 1996;47:1-9.
20. Cordato NJ, Halliday GM, Harding AJ, Hely MA, Morris JGL. Regional brain atrophy in progressive supranuclear palsy and Lewy body disease. Ann Neurol 2000;47:718-728.
21. Double KL, Halliday GM, Kril JJ, Harasty JA, Cullen K, Brooks WS, et al. Topography of brain atrophy during normal aging and Alzheimer's disease. Neurobiol Aging 1996;17:513-521.
22. Double KL, Halliday GM, McRitchie DA, Reid WG, Hely MA, Morris JG. Regional brain atrophy in idiopathic Parkinson's disease and diffuse Lewy body disease. Dementia 1996;7:304-313.
23. Cavalieri B. Geometria indivisiblibus continuourum. Typis clementis ferronij, bononiae. Reprinted 1966 as geometria degli indivisbili. unione Tipografico-Editrice Torinese, Torino 1635.
24. Dekaban AS. Changes in brain weights during the span of human life: relation of brain weights to body heights and weights. Ann Neurol 1978;4:345-356.
25. Schneider JA, Watts RL, Gearing M, Brewer RP, Mirra SS. Corticobasal degeneration: neuropathologic and clinical heterogeneity. Neurology 1997;48:959-969.
26. Hardman CD, Halliday GM, McRitchie DA, Morris JG. The subthalamic nucleus in Parkinson's disease and progressive supranuclear palsy. J Neuropathol Exp Neurol 1997;56:132-142.
27. Halliday GM, Davies L, McRitchie DA, Cartwright H, Pamphlett R, Morris JGL. Ubiquitin-positive achromatic neurons in corticobasal degeneration. Acta Neuropathol 1995;90:68-75.
28. Blin J, Vidailhet MJ, Pillon B, Dubois B, Feve JR, Agid Y. Corticobasal degeneration: decreased and asymmetrical glucose consumption as studied with PET. Mov Disord 1992;7:348-354.
29. Sawle GV, Brooks DJ, Marsden CD, Frackowiak RS. Corticobasal degeneration. A unique pattern of regional cortical oxygen hypometabolism and striatal fluorodopa uptake demonstrated by positron emission tomography. Brain 1991;114:541-556.
30. Nagasawa H, Tanji H, Nomura H, Saito H, Itoyama Y, Kimura I, et al. PET study of cerebral glucose metabolism and fluorodopa uptake in patients with corticobasal degeneration. J Neurol Sci 1996;139:210-217.
31. Laureys S, Salmon E, Garraux G, Peigneux P, Lemaire C, Degueldre C, et al. Fluorodopa uptake and glucose metabolism in early stages of corticobasal degeneration. J Neurol 1999;246:1151-1158.
32. Markus HS, Lees AJ, Lennox G, Marsden CD, Costa DC. Patterns of regional cerebral blood flow in corticobasal degeneration studies among HMPAO SPECT; comparison with Parkinson's disease and normal controls. Mov Disord 1995;10:179-187.
33. Okuda B, Tachibana H, Takeda M, Kawabata K, Sugita M, Fukuchi M. Focal cortical hypoperfusion in corticobasal degeneration demonstrated by three-dimensional surface display with 123I-IMP: a possible cause of apraxia. Neuroradiology 1995;37:642-644.
34. Okuda B, Tachibana H, Kawabata K, Takeda M, Sugita M. Cerebral blood flow in corticobasal degeneration and progressive supranuclear palsy. Alzheimer Dis Assoc Disord 2000;14:46-52.
35. Hauser RA, Murtaugh FR, Akhter K, Gold M, Olanow CW. Magnetic resonance imaging of corticobasal degeneration. J Neuroimaging 1996;6:222-226.
36. Tokumaru AM, O'Uchi T, Kuru Y, Maki T, Murayama S, Horichi Y. Corticobasal degeneration: MR with histopathologic comparison. AJNR Am J Neuroradiol 1996;17:1849-1852.
37. Ballan G, Tison F, Dousset V, Vidailhet M, Agid Y, Henry P. MRI in corticobasal degeneration. Rev Neurol (Paris) 1998;154:224-227.
38. Soliveri P, Monza D, Paridi D, Radice D, Grisoli M, Testa D, et al. Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy. Neurology 1999; 53:502-507.
39. Litvan I, Campbell C, Verny M, McKee K, Ray Chaudhuri K, Jellinger K, et al. Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study. Brain 1997;120:65-74.
40. Bergeron C, Pollanen MS, Weyer L, Black SE, Lang AE. Unusual clinical presentations of cortical-basal ganglionic degeneration. Ann Neurol 1996;40:893-900.
41. Pillon B, Blin J, Vidailhet M, Deweer B, Sirigu A, Dubois B, et al. The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer's disease. Neurology 1995;45:1477-1483.
42. Grimes DA, Lang AE, Bergeron CB. Dementia as the most common presentation of cortical-basal ganglionic degeneration. Neurology 1999;53:1969-1974.
43. Bigio EH, Brown DF, White CL, 3rd. Progressive supranuclear palsy with dementia: cortical pathology. J Neuropathol Exp Neurol 1999;58:359-364.
44. Bergeron C, Davis A, Lang AE. Corticobasal ganglionic degeneration and progressive supranuclear palsy presenting with cognitive decline. Brain Pathol 1998;8:355-365.
45. Bucher SF, Seelos KC, Dodel RC, Paulus W, Reiser M, Oertel W. Pallidal lesions. Structural and functional magnetic resonance imaging. Arch Neurol 1996;53:682-686.
46. Marsden CD. The mysterious motor function of the basal ganglia: the Robert Wartenberg lecture. Neurology 1982;32:514-539.
47. Hallett M. Physiology of basal ganglia disorders: an overview. Can J Neurol Sci 1993;20:177-183.
48. Giroud M, Lemesle M, Madinier G, Billiar T, Dumas R. Unilateral lenticular infarcts: radiological and clinical syndromes, aetiology, and prognosis. J Neurol Neurosurg Psychiatry 1997;63:611-615.
49. Vitek JL, Bakay RAE. The role of pallidotomy in Parkinson's disease and dystonia. Curr Opin Neurol 1997;10:332-339.
50. Rinne JO, Lee MS, Thompson PD, Marsden CD. Corticobasal degeneration. A clinical study of 36 cases. Brain 1994;117:1183-1196.
51. Halliday GM, Hardman CD, Cordato NJ, Hely MA, Morris JG. A role for the substantia nigra pars reticulata in the gaze palsy of progressive supranuclear palsy. Brain 2000;123:724-732.
52. Lang A, Riley D, Bergeron C. Cortico-basal ganglionic degeneration. 4 ed. Philadelphia: WB Saunders; 1994.
53. Leiguarda RC, Marsden CD. Limb apraxias: high-order disorders of sensorimotor integration. Brain 2000;123:860-879.
54. Leiguarda R, Lees AJ, Merello M, Starkstein S, Marsden CD. The nature of apraxia in corticobasal degeneration. J Neurol Neurosurg Psychiatry 1994;57:455-459.
55. Jacobs DH, Adair JC, Macauley B, Gold M, Gonzalez Rothi LJ, Heilman KM. Apraxia in corticobasal degeneration. Brain Cogn 1999;40:336-354.
56. Heilman KM, Gonzalez Rothi LJ. Apraxia. In: Heilman KM, Valenstein E, editors. Clinical neuropsychology. 3 ed. New York: Oxford University Press, Inc.; 1993. p 141-163.
57. Soros P, Knecht S, Imai T, Gurtler S, Lutkenhoner B, Ringelstein EB, et al. Cortical asymmetries of the human somatosensory hand representation in right- and left-handers. Neurosci Lett 1999;271: 89-92.
58. Meador KJ, Ray PG, Day L, Ghelani H, Loring D. Physiology of somatosensory perception: cerebral lateralization and extinction. Neurology 1998;51:721-727.